NL8105788A - Werkwijze ter bereiding van een anti-tetanusvaccin. - Google Patents
Werkwijze ter bereiding van een anti-tetanusvaccin. Download PDFInfo
- Publication number
- NL8105788A NL8105788A NL8105788A NL8105788A NL8105788A NL 8105788 A NL8105788 A NL 8105788A NL 8105788 A NL8105788 A NL 8105788A NL 8105788 A NL8105788 A NL 8105788A NL 8105788 A NL8105788 A NL 8105788A
- Authority
- NL
- Netherlands
- Prior art keywords
- tetanus
- virus
- vaccine
- preparing
- tongue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES502887A ES502887A0 (es) | 1981-06-09 | 1981-06-09 | Procedimiento para la produccion de vacuna antitetanica ad- ministrable por via sublingual |
ES502887 | 1981-06-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8105788A true NL8105788A (nl) | 1983-01-03 |
Family
ID=8482510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8105788A NL8105788A (nl) | 1981-06-09 | 1981-12-22 | Werkwijze ter bereiding van een anti-tetanusvaccin. |
Country Status (9)
Country | Link |
---|---|
BE (1) | BE891457A (el) |
DE (1) | DE3219589A1 (el) |
ES (1) | ES502887A0 (el) |
FR (1) | FR2507079A1 (el) |
GB (1) | GB2110085A (el) |
GR (1) | GR77319B (el) |
IT (1) | IT1140348B (el) |
NL (1) | NL8105788A (el) |
PT (1) | PT73327B (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2851222B1 (fr) | 2003-02-17 | 2006-12-01 | Mavic Sa | Dispositif de commande de changement de vitesse pour un velo et velo equipe d'un tel dispositif |
-
1981
- 1981-06-09 ES ES502887A patent/ES502887A0/es active Granted
- 1981-07-07 PT PT73327A patent/PT73327B/pt unknown
- 1981-12-08 GB GB08137029A patent/GB2110085A/en not_active Withdrawn
- 1981-12-09 FR FR8123138A patent/FR2507079A1/fr not_active Withdrawn
- 1981-12-14 BE BE2/59500A patent/BE891457A/fr unknown
- 1981-12-16 IT IT25628/81A patent/IT1140348B/it active
- 1981-12-21 GR GR66877A patent/GR77319B/el unknown
- 1981-12-22 NL NL8105788A patent/NL8105788A/nl not_active Application Discontinuation
-
1982
- 1982-05-25 DE DE19823219589 patent/DE3219589A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2110085A (en) | 1983-06-15 |
ES8203611A1 (es) | 1982-04-16 |
BE891457A (fr) | 1982-03-31 |
FR2507079A1 (el) | 1982-12-10 |
GR77319B (el) | 1984-09-11 |
DE3219589A1 (de) | 1983-01-13 |
IT8125628A0 (it) | 1981-12-16 |
ES502887A0 (es) | 1982-04-16 |
IT1140348B (it) | 1986-09-24 |
PT73327A (fr) | 1981-08-01 |
PT73327B (fr) | 1982-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68917126T2 (de) | T-zellen-epitope als träger für einen konjugierten impfstoff. | |
Kobayashi | Viral xenogenization of intact tumor cells | |
AU2010256845B2 (en) | Compositions and methods for administration of vaccines against dengue virus | |
Graves et al. | Early response of cattle and swine to inactivated foot-and-mouth disease vaccine | |
DE69610295T2 (de) | Von einem retroviralen regulationsprotein abstammende, detoxifierte immunogene, dagegen gerichtete antikörper, verfahren zur deren herstellung und diese immunogene oder antikörper enthaltende, pharmazeutische zusammensetzungen. | |
FR2610631A1 (fr) | Molecules comportant au moins une sequence peptidique porteuse d'un ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum dans les hepatocytes, et leurs utilisations, notamment pour le diagnostic du paludisme ou dans des compositions de vaccins contre le paludisme | |
EP0841942A1 (fr) | Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu | |
FR2962911A1 (fr) | Composition pharmaceutique d'association destinee a etre utilisee dans un procede pour traiter le trouble d'hyperactivite avec deficit de l'attention | |
DE3781962T2 (de) | Verfahren zur hitzebehandlung von chemisch unmodifiziertem gamma-globulin. | |
Smith et al. | The Chemical Basis of the Virulence of Brucella abortus: IV. Immunogenic Products from Br. abortus Grown in vivo and in vitro | |
NL8105788A (nl) | Werkwijze ter bereiding van een anti-tetanusvaccin. | |
Klosen et al. | Perikaryal neurofilament phosphorylation in axotomized and 6-OH-dopamine-lesioned CNS neurons | |
Boroff | Studies of the toxin of Clostridium botulinum. IV. Fluorescence of Clostridium botulinum toxin and its relation to toxicity | |
US4615884A (en) | Method and vaccine for treatment of demyelinating diseases | |
SU490824A1 (ru) | Способ инактивации инфекциозности вирусов | |
Tsao et al. | Paired trial of cyclophosphamide and prednisone in children with nephrosis | |
KR20190069479A (ko) | 저분자화 PRP를 사용한 Hib 컨쥬게이트 백신의 제조방법 | |
Shwartzman | Further studies on the nature of the phenomenon of local skin reactivity to bacterial filtrates: toxic factors derived from the blood serum | |
FR2479000A1 (fr) | Vaccin contre la brucellose, maladie du betail | |
Rotterman et al. | Modulation of central synapse remodeling after remote peripheral injuries by the CCL2-CCR2 axis and microglia | |
Battisto et al. | Dextran's regulatory effect on immunoglobulin synthesis is mediated through T cells | |
EP0106727B1 (en) | Method of improving parenterally administerable physiologically active compositions by incorporating therein an epsilon-aminocaproic acid or tranexamic acid | |
Ramselaar et al. | Non-immunological regression of dimethylbenz (A) anthracene-induced experimental keratoacanthomas in the rabbit | |
Natali et al. | Immune complex formation in NZBW mice after ultraviolet radiation | |
RU2081170C1 (ru) | Соединение на основе макропористого сополимера стирола и дивинилбензола в качестве иммуносорбента для удаления дифтерийного токсина из биологических жидкостей организма |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BV | The patent application has lapsed |